2192.HK HKSE
Medlive Technology Co., Ltd.
1W: -6.7%
1M: -11.2%
3M: -14.0%
YTD: -36.0%
1Y: -56.9%
3Y: +4.5%
HK$6.33 ($0.81)
-0.10 (-1.48%)
Weekly Expected Move ±4.3%
HK$6
HK$6
HK$6
HK$7
HK$7
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$626M
+12.0% ▲
5Y CAGR: +24.0%
Gross Profit
$360M
+10.1% ▲
5Y CAGR: +18.2%
Operating Income
$165M
+207.0% ▲
5Y CAGR: +13.4%
Net Income
$326M
+3.3% ▲
5Y CAGR: +30.8%
EPS (Diluted)
$0.44
+2.3% ▲
5Y CAGR: +29.7%
EBITDA
$185M
+52.7% ▲
5Y CAGR: +10.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $284M | $314M | $412M | $558M | $626M |
| YoY Growth | +33.2% | +10.4% | +31.2% | +35.5% | +12.0% |
| Cost of Revenue | $84M | $101M | $161M | $231M | $265M |
| Gross Profit | $201M | $213M | $251M | $327M | $360M |
| Gross Margin | 70.6% | 67.7% | 61.0% | 58.6% | 57.6% |
| R&D Expenses | $25M | $46M | $0 | $65M | $75M |
| SG&A Expenses | $128M | $151M | $177M | $209M | $121M |
| Operating Expenses | $153M | $198M | $232M | $274M | $195M |
| Operating Income | $48M | $15M | $20M | $54M | $165M |
| Operating Margin | 16.8% | 4.8% | 4.8% | 9.6% | 26.3% |
| Interest Expense | $535K | $531K | $361K | $786K | $538K |
| Income Before Tax | $70M | $135M | $253M | $340M | $351M |
| Tax Expense | $25M | $9M | $1M | $10M | $12M |
| Net Income | $41M | $117M | $242M | $315M | $326M |
| Net Margin | 14.3% | 37.4% | 58.8% | 56.4% | 52.1% |
| EPS (Diluted) | $0.06 | $0.16 | $0.33 | $0.43 | $0.44 |
| EBITDA | $77M | $145M | $263M | $121M | $185M |
| Shares Outstanding | 636M | 737M | 735M | 736M | 737M |